Proto Labs (PRLB) Tops Q3 EPS by 8c, Beats on Revenue; Offers Q4 Guidance

Proto Labs (NYSE: PRLB) reported Q3 EPS of $0.47, $0.08 better than the analyst estimate of $0.39. Revenue for the quarter came in at $135.4 million versus the consensus estimate of $133.86 million.

GUIDANCE:

Proto Labs sees Q4 2025 EPS of $0.30-$0.38, versus the consensus of $0.33.

For earnings history and earnings-related data on Proto Labs (PRLB) click here.

You May Also Be Interested In

• U.S. and Denmark close in on a Greenland deal - Reuters
• Axion Minerals plans flow-through private placement of up to $440K
• Teva shares Phase 3 data on once-monthly schizophrenia injection